ReviewRSC advances2026
Bridging bioceramics and advanced 2D/porous materials: a review of hydroxyapatite/metal-organic framework and hydroxyapatite/MXene composites.
Review in RSC advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hydroxyapatite (HAp) is a well-known bioceramic material with excellent biocompatibility, bioactivity, and chemical stability. However, its brittleness, low surface reactivity, and limited functionality restrict its use in advanced applications such as drug delivery, catalysis, and sensing. To overcome these limitations, HAp has recently been combined with metal-organic frameworks (MOFs) and MXenes, two emerging classes of functional materials. MOFs provide high surface area and tunable porosity, whereas MXenes offer excellent electrical conductivity and photothermal properties. In turn, HAp enhances the structural stability of these materials by improving the moisture resistance of MOFs and reducing the restacking tendency of MXenes. In both types of composites, HAp primarily acts as a bioactive and ion-rich support, while the MOF or MXene component provides the desired functional properties. This common design strategy forms the basis of the present review, which is the first to comparatively discuss HAp/MOF and HAp/MXene composites within a single framework. The review summarizes their synthesis methods and applications in biomedical engineering, environmental remediation, catalysis, electrochemical sensing, coatings, and agriculture. More importantly, it critically examines whether the reported performance improvements arise from true synergistic interactions or simply from the individual contributions of each component. It also compares the reproducibility of different fabrication strategies, discusses the distinct mechanisms through which HAp improves the stability of MOFs and MXenes, and evaluates the maturity of reported applications based on real-sample testing and
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.